Discover
ACRS
Aclaris Therapeutics, Inc.
5.34
2 x 4.03
2 x 6.74
bid
ask
+
0.05
0.95%
2 @ 05:58 AM
5.24 -0.10 (1.87%)
| Ytd | 77.41% | |
| 1y | 278.72% |
5.24
day range
5.69
1.39
52 week range
5.69
| Open | 5.59 | Prev Close | 5.29 | Low | 5.24 | High | 5.69 | Mkt Cap | 745.80M |
| Vol | 2.39M | Avg Vol | 1.53M | EPS | -0.56 | P/E | N/A | Forward P/E | -5.00 |
| Beta | 0.12 | Short Ratio | 0.47 | Inst. Own | 90.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.59 | 200-d Avg | 3.36 | 1yr Est | 10.00 |
| Income Statement | |||
| Total Revenue | 2.00M | ||
| Revenues (USD) | 2.00M | ||
| Cost of Revenue | 1.79M | ||
| Gross Profit | 208.00K | ||
| Operating Expenses | 22.40M | ||
| Research and Development Expense | 15.66M | ||
| Selling, General and Administrative Expense | 6.74M | ||
| Operating Income | -22.19M | ||
| Net Income | -19.82M | ||
| Net Income Common Stock | -19.82M | ||
| Net Income Common Stock (USD) | -19.82M | ||
| Consolidated Income | -19.82M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -19.82M | ||
| Earning Before Interest & Taxes (USD) | -19.82M | ||
| Weighted Average Shares | 128.81M | ||
| Weighted Average Shares Diluted | 128.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 28.66M | ||
| Cash and Equivalents (USD) | 28.66M | ||
| Investments | 162.13M | ||
| Investments Current | 76.76M | ||
| Investments Non-Current | 85.37M | ||
| Trade and Non-Trade Receivables | 4.81M | ||
| Current Assets | 110.23M | ||
| Property, Plant & Equipment Net | 750.00K | ||
| Total Assets | 198.72M | ||
| Current Liabilities | 27.37M | ||
| Total Liabilities | 55.07M | ||
| Accumulated Retained Earnings (Deficit) | -987.61M | ||
| Accumulated Other Comprehensive Income | 22.00K | ||
| Shareholders Equity | 143.65M | ||
| Shareholders Equity (USD) | 143.65M | ||
| Assets Non-Current | 88.49M | ||
| Deferred Revenue | 19.26M | ||
| Liabilities Non-Current | 27.70M | ||
| Trade and Non-Trade Payables | 14.73M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 102.00K | ||
| Net Cash Flow from Financing | 57.78M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 8.70M | ||
| Capital Expenditure | -13.00K | ||
| Issuance (Purchase) of Equity Shares | 58.03M | ||
| Net Cash Flow from Investing | -30.93M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -30.92M | ||
| Net Cash Flow from Operations | -18.15M | ||
| Share Based Compensation | 3.20M | ||